2022
DOI: 10.1002/mdc3.13584
|View full text |Cite
|
Sign up to set email alerts
|

Gender Differences in the Prevalence of Parkinson's Disease

Abstract: Background Parkinson's disease (PD) affects males more than females. The reasons for the gender differences in PD prevalence remain unclear. Objective The objective of this systematic review and meta‐analysis was to update the overall male/female prevalence ratios (OPR). Methods We updated previous work by searching MEDLINE, SCOPUS, and OVID for articles reporting PD prevalence for both genders between 2011 and 2021. We calculated OPRs and investigated heterogeneity in effect estimates. Results We included 19 … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
16
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 59 publications
0
16
0
Order By: Relevance
“…Studies have shown that PD affects males more frequently than females, although a recent meta-analysis showed that this difference in prevalence can be lower than expected and is population specific. 3 Biological aging differs distinctly between males and females because of hormonal and immunological changes that females specifically experience, [4][5][6] and this may contribute to the stark differences observed in PD risk, presentation, severity, and treatment success. 7 Even though estrogen is thought to have a protective role in PD risk, [8][9][10] this remains unclear, because multiple studies contradict this hypothesis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies have shown that PD affects males more frequently than females, although a recent meta-analysis showed that this difference in prevalence can be lower than expected and is population specific. 3 Biological aging differs distinctly between males and females because of hormonal and immunological changes that females specifically experience, [4][5][6] and this may contribute to the stark differences observed in PD risk, presentation, severity, and treatment success. 7 Even though estrogen is thought to have a protective role in PD risk, [8][9][10] this remains unclear, because multiple studies contradict this hypothesis.…”
Section: Introductionmentioning
confidence: 99%
“…Sex is an important factor, not only in the development but also in the progression of PD. Studies have shown that PD affects males more frequently than females, although a recent meta‐analysis showed that this difference in prevalence can be lower than expected and is population specific 3 . Biological aging differs distinctly between males and females because of hormonal and immunological changes that females specifically experience, 4‐6 and this may contribute to the stark differences observed in PD risk, presentation, severity, and treatment success 7 .…”
Section: Introductionmentioning
confidence: 99%
“…Sex is an important factor, not only in the development but also in the progression of PD. Studies have shown that PD affects males more frequently than females, although a recent meta-analysis showed that this difference in prevalence can be lower than expected and is population-specific [3]. Biological aging differs distinctly between males and females due to hormonal and immunological changes that females specifically experience [46], and this may contribute to the stark differences observed in PD risk, presentation, severity, and treatment success [7].…”
Section: Introductionmentioning
confidence: 99%
“…In Germany, the number of prevalent PD patients was estimated at 420,000 in 2015 6 . PD incidence increases with age, but stabilizes in the highest ages, and is higher among males 6‐8 …”
Section: Introductionmentioning
confidence: 99%
“…6 PD incidence increases with age, but stabilizes in the highest ages, and is higher among males. [6][7][8] PD is a chronic progressive disease, and is characterized by varying motor symptoms and non-motor symptoms. 2,5,9,10 Parkinson's disease dementia (PDD) as a non-motor manifestation is present in 13% to 85% of PD patients 6,[11][12][13][14][15] and is associated with reduced psychosocial well-being, 16 higher severity of PD, 17 and increased risk of mortality.…”
Section: Introductionmentioning
confidence: 99%